US2444570A
(en)
|
|
1948-07-06 |
|
Drive for counter numeral wheels |
GB735443A
(en)
|
1952-09-02 |
1955-08-24 |
English Numbering Machines |
Improvements in or relating to counting devices
|
US2828742A
(en)
|
1957-05-02 |
1958-04-01 |
American Home Prod |
Cartridge-needle unit
|
BE639963A
(es)
|
1963-05-02 |
|
|
|
US3318289A
(en)
|
1965-05-11 |
1967-05-09 |
Northern Ind Products |
Bi-stable mechanism
|
CH499734A
(de)
|
1968-07-19 |
1970-11-30 |
Kienzle Apparate Gmbh |
Klinkengesperre als Einrichtungs- und Überholkupplung
|
US3758683A
(en)
|
1971-04-30 |
1973-09-11 |
R Jackson |
Insulin product
|
US4282316A
(en)
|
1979-09-11 |
1981-08-04 |
Modrovich Ivan Endre |
Stabilized enzymic solutions for determining urea
|
FI75991C
(fi)
|
1980-03-21 |
1988-09-09 |
Wellcome Found |
Foerfarande foer framstaellning av stabil isotonisk vaetskekomposition, vilken kan anvaendas som oegonmedicinpreparat.
|
US4425346A
(en)
|
1980-08-01 |
1984-01-10 |
Smith And Nephew Associated Companies Limited |
Pharmaceutical compositions
|
GB2109690B
(en)
|
1981-02-12 |
1985-02-20 |
Robert Charles Turner |
Dose metering plunger devices for use with syringes
|
US4568335A
(en)
|
1981-08-28 |
1986-02-04 |
Markwell Medical Institute, Inc. |
Device for the controlled infusion of medications
|
US4394863A
(en)
|
1981-10-23 |
1983-07-26 |
Survival Technology, Inc. |
Automatic injector with cartridge having separate sequentially injectable medicaments
|
DE3204178C2
(de)
|
1982-02-06 |
1986-03-20 |
Eppendorf Gerätebau Netheler + Hinz GmbH, 2000 Hamburg |
Pipettiervorrichtung
|
US4483849A
(en)
|
1983-01-07 |
1984-11-20 |
Carter William A |
Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
|
GB2141799B
(en)
|
1983-06-03 |
1986-07-16 |
Diehl Gmbh & Co |
An adjusting ratchet mechanism for a time switch
|
DE3468173D1
(en)
|
1983-09-07 |
1988-02-04 |
Disetronic Ag |
Portable infusion apparatus
|
US4468346A
(en)
|
1983-10-27 |
1984-08-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Monoclonal antibodies to porcine immunoglobulins
|
JPS60129941U
(ja)
|
1984-02-09 |
1985-08-31 |
テルモ株式会社 |
医療用器具
|
US4592745A
(en)
|
1984-02-29 |
1986-06-03 |
Novo Industri A/S |
Dispenser
|
FR2583291A1
(fr)
|
1985-06-14 |
1986-12-19 |
Hazon Bernard |
Dispositif d'avancement pas a pas du piston de seringues par double vis coaxiale avec controle du debit d'injection. application aux injections medicamenteuses intra-dermiques repetitives
|
DE3546150A1
(de)
|
1985-06-24 |
1987-01-22 |
Hoechst Ag |
Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
|
DE3670768D1
(de)
|
1985-11-08 |
1990-06-07 |
Disetronic Ag |
Injektionsgeraet.
|
DE3609555A1
(de)
|
1986-03-21 |
1987-09-24 |
Josef Porner |
Blutentnahmespritze
|
ATE110083T1
(de)
|
1986-05-05 |
1994-09-15 |
Gen Hospital Corp |
Insulinotropes hormon.
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
US4917685A
(en)
|
1986-05-16 |
1990-04-17 |
International Minerals & Chem. Corp. |
Delivery device for the administration of stabilized growth promoting hormones
|
DE3638984C3
(de)
|
1986-11-14 |
1993-11-18 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
US5716990A
(en)
|
1987-03-09 |
1998-02-10 |
Cancer Research Campaign Technology Limited |
Drug delivery systems
|
DK177187A
(da)
|
1987-04-07 |
1988-10-08 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glasampul
|
DE3715258C2
(de)
|
1987-05-08 |
1996-10-31 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
WO1988008673A1
(en)
|
1987-05-14 |
1988-11-17 |
Commonwealth Scientific And Industrial Research Or |
Whey protein fractions
|
GB8713810D0
(en)
|
1987-06-12 |
1987-07-15 |
Hypoguard Uk Ltd |
Measured dose dispensing device
|
FI883338A
(fi)
|
1987-07-16 |
1989-01-17 |
Bristol Myers Co |
Vattenloesningar av doxorubicinhydroklorid.
|
IT1222331B
(it)
|
1987-08-25 |
1990-09-05 |
Bruno Micovilovich |
Siringa di sicurezza per usi parentali,a disimpegno autonomo e rapido dell'ago dopo l'uso
|
US4919596A
(en)
|
1987-12-04 |
1990-04-24 |
Pacesetter Infusion, Ltd. |
Fluid delivery control and monitoring apparatus for a medication infusion system
|
US4833379A
(en)
|
1988-01-13 |
1989-05-23 |
Sherwood Medical Company |
Motor control fail-safe circuit
|
CH675078A5
(es)
|
1988-01-22 |
1990-08-31 |
Nosta Ag |
|
DE3900926C2
(de)
|
1988-02-08 |
1999-05-12 |
Disetronic Licensing Ag |
Spritzenförmiges Injektionsgerät und Injektionsgerätebaukasten
|
US4973318A
(en)
|
1988-02-10 |
1990-11-27 |
D.C.P. Af 1988 A/S |
Disposable syringe
|
DK166948B1
(da)
|
1988-02-10 |
1993-08-09 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glastubule
|
WO1990000200A1
(en)
|
1988-06-27 |
1990-01-11 |
Genex Corporation |
Thermal release of recombinant protein into culture media
|
EP0359070B1
(de)
|
1988-09-12 |
1995-01-11 |
Grässlin Kg |
Richtgesperre für eine Schaltuhr
|
GB8900763D0
(en)
|
1989-01-13 |
1989-03-08 |
Kabi Vitrum Peptide Hormones A |
Multi-dose syringe
|
US5216437A
(en)
|
1989-02-02 |
1993-06-01 |
Canon Kabushiki Kaisha |
Ink, and recording method making use of same
|
DK68789A
(da)
|
1989-02-14 |
1990-08-15 |
Novo Nordisk As |
Injektionspen
|
HU203372B
(en)
|
1989-02-24 |
1991-07-29 |
Richter Gedeon Vegyeszet |
Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
|
DE68929217T2
(de)
|
1989-03-20 |
2000-11-30 |
Gen Hospital Corp |
Insulinotropes hormon
|
JP2822447B2
(ja)
|
1989-05-19 |
1998-11-11 |
住友電気工業株式会社 |
酸化物超電導線材の製造方法および装置
|
US4994033A
(en)
|
1989-05-25 |
1991-02-19 |
Schneider (Usa) Inc. |
Intravascular drug delivery dilatation catheter
|
US5226895A
(en)
|
1989-06-05 |
1993-07-13 |
Eli Lilly And Company |
Multiple dose injection pen
|
DE3927286C2
(de)
|
1989-08-18 |
1997-07-24 |
Roehm Gmbh |
Wäßrige Enzym-Flüssigformulierungen
|
US5216011A
(en)
|
1989-09-01 |
1993-06-01 |
Bristol-Myers Squibb Co. |
Stable solutions of mitomycin c
|
DE69013471T2
(de)
|
1989-12-05 |
1995-03-30 |
Merck & Co Inc |
Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
|
DK17890A
(da)
|
1990-01-22 |
1991-07-23 |
Novo Nordisk As |
Fremgangsmaade og apparat til opblanding og injicering af et laegemiddel
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
EP0512042B1
(en)
|
1990-01-24 |
1998-04-08 |
BUCKLEY, Douglas I. |
Glp-1 analogs useful for diabetes treatment
|
DE4002066A1
(de)
|
1990-01-25 |
1991-08-01 |
Basf Ag |
Verfahren zur abtrennung von riboflavin aus fermentationssuspensionen
|
GB9007113D0
(en)
|
1990-03-29 |
1990-05-30 |
Sams Bernard |
Dispensing device
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
US5492534A
(en)
|
1990-04-02 |
1996-02-20 |
Pharmetrix Corporation |
Controlled release portable pump
|
US5318540A
(en)
|
1990-04-02 |
1994-06-07 |
Pharmetrix Corporation |
Controlled release infusion device
|
US5226896A
(en)
|
1990-04-04 |
1993-07-13 |
Eli Lilly And Company |
Dose indicating injection pen
|
IT220491Z2
(it)
|
1990-04-13 |
1993-09-24 |
Stilolinea Srl |
Penna a sfera del tipo a punta scrivente rientrante
|
EP0532546B1
(en)
|
1990-05-10 |
1998-03-18 |
Bechgaard International Research And Development A/S |
A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
|
US5257987A
(en)
|
1990-05-21 |
1993-11-02 |
Pharmetrix Corporation |
Controlled release osmotic infusion system
|
JP3042710B2
(ja)
|
1990-09-21 |
2000-05-22 |
ノボ ノルディスク アクティーゼルスカブ |
ペンシリンジアセンブリー
|
US5284480A
(en)
|
1990-11-09 |
1994-02-08 |
Medtronic, Inc. |
Inflation/deflation syringe with threaded plunger
|
GB9026191D0
(en)
|
1990-12-01 |
1991-01-16 |
Harris Pharma Ltd |
Breath actuated dispensing device
|
US5331954A
(en)
|
1990-12-21 |
1994-07-26 |
Novo Nordisk A/S |
Device for nasal delivery of liquid medications
|
US5232706A
(en)
|
1990-12-31 |
1993-08-03 |
Esteve Quimica, S.A. |
Oral pharmaceutical preparation containing omeprazol
|
AU641206B2
(en)
|
1991-01-22 |
1993-09-16 |
Eli Lilly And Company |
Multiple dose injection pen
|
EP0498737B1
(en)
|
1991-02-07 |
1995-07-19 |
Terumo Kabushiki Kaisha |
Dosing means for an injector
|
US5272135A
(en)
|
1991-03-01 |
1993-12-21 |
Chiron Ophthalmics, Inc. |
Method for the stabilization of methionine-containing polypeptides
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
US5571719A
(en)
|
1991-03-27 |
1996-11-05 |
Novo Nordisk A/S |
Catalase, its production and use
|
US5258377A
(en)
|
1991-04-08 |
1993-11-02 |
Taiho Pharmaceutical Co., Ltd. |
2-spirocyclopropyl 4-acylcephems
|
DE4112259A1
(de)
|
1991-04-15 |
1992-10-22 |
Medico Dev Investment Co |
Injektionsgeraet
|
DK68991D0
(da)
|
1991-04-17 |
1991-04-17 |
Novo Nordisk As |
Manifold
|
US5645052A
(en)
|
1991-04-26 |
1997-07-08 |
The Boc Group Plc |
Anaesthetic vaporizer with expandable/contractable reservoir for pumping liquid anaesthetic
|
SE9101381D0
(sv)
|
1991-05-07 |
1991-05-07 |
Tomas Moks |
Peptide hormone solution
|
DK0525525T3
(da)
|
1991-07-24 |
1995-10-02 |
Medico Dev Investment Co |
Injektor
|
DK175491D0
(da)
|
1991-10-18 |
1991-10-18 |
Novo Nordisk As |
Apparat
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
DK194291D0
(da)
|
1991-11-29 |
1991-11-29 |
Novo Nordisk As |
Sproejte til automatisk injektion.
|
ATE144432T1
(de)
|
1991-11-29 |
1996-11-15 |
Novo Nordisk As |
Stiftförmige spritze
|
US5246417A
(en)
|
1991-12-11 |
1993-09-21 |
Alza Corporation |
Indicator for iontophoresis system
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
FR2686460B1
(fr)
|
1992-01-20 |
1994-03-11 |
Labinal Precision Mecanique |
Organe de contact electrique femelle.
|
US5279586A
(en)
|
1992-02-04 |
1994-01-18 |
Becton, Dickinson And Company |
Reusable medication delivery pen
|
CH682968B5
(fr)
|
1992-02-12 |
1994-06-30 |
Rolex Montres |
Procédé de fabrication d'un joint et joint pour dispositif de commande étanche pour montre obtenu selon ce procédé.
|
CH682806A5
(de)
|
1992-02-21 |
1993-11-30 |
Medimpex Ets |
Injektionsgerät.
|
DE4208677A1
(de)
|
1992-03-18 |
1993-09-23 |
Injecta Gmbh Steinach |
Injektionsvorrichtung, insbesondere fuer sehgeschaedigte diabetiker
|
DK36492D0
(da)
|
1992-03-19 |
1992-03-19 |
Novo Nordisk As |
Praeparat
|
WO1993018812A1
(en)
|
1992-03-25 |
1993-09-30 |
Tebro S.A. |
Powder jet dispenser for medicament inhalation therapies
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
US5271527A
(en)
|
1992-04-02 |
1993-12-21 |
Habley Medical Technology Corporation |
Reusable pharmaceutical dispenser with full stroke indicator
|
US5281198A
(en)
|
1992-05-04 |
1994-01-25 |
Habley Medical Technology Corporation |
Pharmaceutical component-mixing delivery assembly
|
JP3631490B2
(ja)
|
1992-05-13 |
2005-03-23 |
ノバルティス ファーマ株式会社 |
シクロスポリン含有眼科用組成物
|
KR0154880B1
(ko)
|
1992-06-15 |
1998-10-15 |
피터 알.셰어러 |
글루카곤-유사 펩티드 및 인슐리노트로핀 유도체
|
UA26190C2
(uk)
|
1992-07-28 |
1999-07-19 |
Сейфтек Ай Лімітед |
Шприц
|
GB9219849D0
(en)
|
1992-09-19 |
1992-10-28 |
Hypoguard Uk Ltd |
Device
|
JP3660678B2
(ja)
|
1992-10-15 |
2005-06-15 |
ザ ゼネラル ホスピタル コーポレーション |
電子的にロード可能な薬剤ライブラリ付き注入ポンプ
|
US5545147A
(en)
|
1992-10-20 |
1996-08-13 |
Eli Lilly And Company |
Anti-backup improvement for hypodermic syringes
|
US5378233A
(en)
|
1992-11-18 |
1995-01-03 |
Habley Medical Technology Corporation |
Selected dose pharmaceutical dispenser
|
US5320609A
(en)
|
1992-12-07 |
1994-06-14 |
Habley Medical Technology Corporation |
Automatic pharmaceutical dispensing syringe
|
GB9226423D0
(en)
|
1992-12-18 |
1993-02-10 |
Sams Bernard |
Incrementing mechanisms
|
ES2133535T3
(es)
|
1993-02-19 |
1999-09-16 |
Sanofi Sa |
Jeringa precargada para el almacenamiento y la transferencia de una sustancia medicamentosa liquida y esteril.
|
US5383865A
(en)
|
1993-03-15 |
1995-01-24 |
Eli Lilly And Company |
Medication dispensing device
|
ZA941881B
(en)
|
1993-04-02 |
1995-09-18 |
Lilly Co Eli |
Manifold medication injection apparatus and method
|
US5584815A
(en)
|
1993-04-02 |
1996-12-17 |
Eli Lilly And Company |
Multi-cartridge medication injection device
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
SE9301494D0
(sv)
|
1993-04-30 |
1993-04-30 |
Kabi Pharmacia Ab |
A device for dosing liquid preparation
|
DK52393D0
(es)
|
1993-05-05 |
1993-05-05 |
Novo Nordisk As |
|
AU7531094A
(en)
|
1993-08-24 |
1995-03-21 |
Novo Nordisk A/S |
Protracted glp-1
|
WO1995007931A1
(en)
|
1993-09-17 |
1995-03-23 |
Novo Nordisk A/S |
Acylated insulin
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
CA2176462A1
(en)
|
1993-11-19 |
1995-05-26 |
Larry P. Feigen |
Transdermal composition of n-[n-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-l-.alpha.-aspartyl]-l-phenylalanine or its esters and their pharmaceutically acceptable salts
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
US5478316A
(en)
|
1994-02-02 |
1995-12-26 |
Becton, Dickinson And Company |
Automatic self-injection device
|
US5514097A
(en)
|
1994-02-14 |
1996-05-07 |
Genentech, Inc. |
Self administered injection pen apparatus and method
|
US5562623A
(en)
|
1994-02-14 |
1996-10-08 |
Univec |
Single-use syringe assembly including spring clip lock and plunger
|
WO1995022560A1
(en)
|
1994-02-22 |
1995-08-24 |
The Syntex-Synergen Neuroscience Joint Venture |
Pharmaceutical formulations of cntf
|
US5741688A
(en)
|
1994-05-03 |
1998-04-21 |
Novo Nordisk A/S |
Alkaline glucose oxidase obtained from cladosporium oxysporum
|
GB9409496D0
(en)
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
US5750140A
(en)
|
1994-05-20 |
1998-05-12 |
Novo Nordisk A/S |
Transdermal delivery of tiagabine
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
WO1995034334A1
(en)
|
1994-06-15 |
1995-12-21 |
Interventional Research Technologies, Inc. |
Locking device for syringe or like instrument
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5827232A
(en)
|
1994-06-22 |
1998-10-27 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
US5725508A
(en)
|
1994-06-22 |
1998-03-10 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
US5440976A
(en)
|
1994-08-23 |
1995-08-15 |
Fred Giuliano |
Adjustable dispensing stirrer for soluble sweeteners
|
US5823998A
(en)
|
1994-08-24 |
1998-10-20 |
Eli Lilly Japan Kabushiki Kaisha |
Injection apparatus
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
US5549574A
(en)
|
1994-08-30 |
1996-08-27 |
Eli Lilly And Company |
Cartridge assembly for use in a pen-type medicament injector
|
CA2157219C
(en)
|
1994-08-31 |
2010-10-05 |
Munehiro Noda |
Process for purifying recombinant human serum albumin
|
KR970705343A
(ko)
|
1994-09-09 |
1997-10-09 |
안네 제케르 |
콘택트 렌즈의 세척, 살균 및 보존(cleaning, disinfecting and preserving contact lenses)
|
US5549575A
(en)
|
1994-09-13 |
1996-08-27 |
Becton Dickinson And Company |
Cartridge retainer assembly for medication delivery pen
|
US5582598A
(en)
|
1994-09-19 |
1996-12-10 |
Becton Dickinson And Company |
Medication delivery pen with variable increment dose scale
|
BR9508847A
(pt)
|
1994-09-20 |
1999-11-30 |
Novo Nordisk A S E Slagterisel |
Processo para tratar uma solução aquosa de proteìna e para produzir um gênero alimentìcio à base de carne, mistura de solução de proteìna/hidrolisado tratada com calor, ou hidrolisado lìquido tratado com calor, gênero alimentìcio à base de carne e uso da mistura de solução de proteìna/hidrolisado tratada com calor, ou de hidrolisado lìquido tratado com calor
|
ZA958073B
(en)
|
1994-09-28 |
1996-04-23 |
Anthony William Manicom |
Method of and apparatus for administering a drug to a patient
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
ATE234625T1
(de)
|
1994-12-23 |
2003-04-15 |
Novo Nordisk As |
Glp-1 zusammensetzungen mit verlängerter wirkdauer
|
DE69637940D1
(de)
|
1995-02-03 |
2009-07-09 |
Novozymes As |
Eine methode zum entwurf von alpha-amylase mutanten mit vorbestimmten eigenschaften
|
DE69620877T2
(de)
|
1995-02-06 |
2002-12-12 |
Genetics Inst |
Arzneimittelformulierungen für il-12
|
GB9503969D0
(en)
|
1995-02-28 |
1995-04-19 |
Sams Bernard |
Incrementing mechanism
|
NZ302558A
(en)
|
1995-03-07 |
1999-11-29 |
Lilly Co Eli |
Dispensing apparatus with a medication cartridge with a manually adjustable metering mechanism
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
CN1196061A
(zh)
|
1995-03-17 |
1998-10-14 |
诺沃挪第克公司 |
胰岛素衍生物
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
PT840628E
(pt)
|
1995-06-02 |
2002-10-31 |
Novo Nordisk As |
Suspensao automatica de haste de pistao
|
AU5996996A
(en)
|
1995-06-02 |
1996-12-18 |
Novo Nordisk A/S |
Al/fe-treatment of a protein solution, followed by membrane concentration
|
US5631347A
(en)
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
JP3895377B2
(ja)
|
1995-06-13 |
2007-03-22 |
ノボザイムス アクティーゼルスカブ |
酵素安定剤としての4−置換フェニルボロン酸
|
US5688251A
(en)
|
1995-09-19 |
1997-11-18 |
Becton Dickinson And Company |
Cartridge loading and priming mechanism for a pen injector
|
US5674204A
(en)
|
1995-09-19 |
1997-10-07 |
Becton Dickinson And Company |
Medication delivery pen cap actuated dose delivery clutch
|
JP3060287B2
(ja)
|
1995-10-09 |
2000-07-10 |
参天製薬株式会社 |
アパファントを主薬とする水性点眼剤
|
US5899879A
(en)
|
1995-12-19 |
1999-05-04 |
Genesis Medical Technologies, Inc. |
Spring-actuated needleless injector
|
AU708528B2
(en)
|
1996-02-23 |
1999-08-05 |
Novo Nordisk A/S |
Syringe with electronic representation of parameters
|
AU722303C
(en)
|
1996-03-05 |
2001-12-06 |
Robert Gurny |
Pharmaceutical compositions containing buffered ortho ester polymers
|
DE69735089T2
(de)
|
1996-03-12 |
2006-08-31 |
Novo Nordisk A/S |
Injektionsvorrichtung mit elektronischer anzeige von eingestellten dosierungen
|
WO1997036626A1
(de)
|
1996-04-02 |
1997-10-09 |
Disetronic Licensing Ag |
Injektionsgerät
|
AU724937B2
(en)
|
1996-04-24 |
2000-10-05 |
Novo Nordisk A/S |
Injection needle
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
DE69722620T2
(de)
|
1996-07-03 |
2004-04-29 |
Alza Corp., Palo Alto |
Nicht-waessrige protische peptidzubereitungen
|
PL330757A1
(en)
|
1996-07-05 |
1999-05-24 |
Novo Nordisk As |
Elastic piston rod
|
DE69724784T2
(de)
|
1996-07-05 |
2004-07-15 |
Novo Nordisk A/S |
Vorrichtung zur automatischen einführung einer nadel
|
PL330817A1
(en)
|
1996-07-05 |
1999-06-07 |
Novo Nordisk As |
Dose establishing device
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
US5962407A
(en)
|
1996-07-26 |
1999-10-05 |
Kelly; Michael T. |
Loloatin derivatives and analogs
|
DE69739172D1
(de)
|
1996-08-08 |
2009-01-29 |
Amylin Pharmaceuticals Inc |
Regulation gastrointestinaler beweglichkeit
|
JPH10101696A
(ja)
|
1996-08-08 |
1998-04-21 |
Shinotesuto:Kk |
形質転換体にて発現される蛋白質に含まれる夾雑物質の除去方法及び精製蛋白質
|
US5843036A
(en)
|
1996-08-23 |
1998-12-01 |
Becton Dickinson And Company |
Non-dosing cartridge for an injection device
|
US5709662A
(en)
|
1996-08-23 |
1998-01-20 |
Becton Dickinson France, S.A. |
Cartridge for an injection device
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
CA2468374C
(en)
|
1996-08-30 |
2010-12-21 |
Novo-Nordisk A/S |
Glp-1 derivatives
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
US5947934A
(en)
|
1996-09-13 |
1999-09-07 |
Novo Nordisk A/S |
Dose display for an injection syringe
|
KR100464845B1
(ko)
|
1996-09-13 |
2005-01-05 |
노보 노르디스크 에이/에스 |
주사기용 투여량 디스플레이
|
US6110149A
(en)
|
1996-09-13 |
2000-08-29 |
Novo Nordisk A/S |
Syringe
|
US6379339B1
(en)
|
1996-09-13 |
2002-04-30 |
Nova Nordisk A/S |
Syringe
|
EP0927055B1
(en)
|
1996-09-20 |
2001-12-05 |
Novo Nordisk A/S |
Working cylinder
|
US6146361A
(en)
|
1996-09-26 |
2000-11-14 |
Becton Dickinson And Company |
Medication delivery pen having a 31 gauge needle
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
TW524667B
(en)
|
1996-12-05 |
2003-03-21 |
Pfizer |
Parasiticidal pyrazoles
|
US5954689A
(en)
|
1996-12-20 |
1999-09-21 |
Novo Nordisk A/S |
Jet injector
|
DE122007000044I2
(de)
|
1997-01-07 |
2011-05-05 |
Amylin Pharmaceuticals Inc |
Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
TW503113B
(en)
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
CA2278199A1
(en)
|
1997-01-20 |
1998-07-23 |
Japan Energy Corporation |
Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
|
GB2321419B
(en)
|
1997-01-27 |
2001-02-07 |
Medic Aid Ltd |
Atomizer
|
EP0971760A1
(en)
|
1997-02-04 |
2000-01-19 |
Novo Nordisk A/S |
A device for the administration of a liquid medicament suspension
|
DE29703820U1
(de)
|
1997-03-03 |
1998-07-02 |
Medico Development Investment Co., Ascona |
Injektionsgerät
|
US5898028A
(en)
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
US20010020155A1
(en)
|
1997-03-25 |
2001-09-06 |
Soren Mikkelsen |
Injection system
|
WO1998043658A1
(en)
|
1997-03-31 |
1998-10-08 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
CA2236519C
(en)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
US7101853B2
(en)
|
1997-05-06 |
2006-09-05 |
Amylin Pharmaceuticals, Inc. |
Method for treating or preventing gastritis using amylin or amylin agonists
|
RU2111019C1
(ru)
|
1997-05-22 |
1998-05-20 |
Сергей Александрович Хворостов |
Универсальный инъектор
|
ATE277948T1
(de)
|
1997-05-23 |
2004-10-15 |
Predrag Sikiric |
Bpc peptid salze mit organ-schützender aktivität, deren herstellung und therapeutische verwendung
|
US7910548B2
(en)
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
US6074372A
(en)
|
1997-06-09 |
2000-06-13 |
Novo Nordisk A/S |
Dose setting mechanism and an injection syringe having such a dose setting mechanism
|
WO1998056381A1
(en)
|
1997-06-09 |
1998-12-17 |
Bridge Pharma, Inc. |
Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
|
US6003736A
(en)
|
1997-06-09 |
1999-12-21 |
Novo Nordisk A/S |
Device for controlled dispensing of a dose of a liquid contained in a cartridge
|
ZA984697B
(en)
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
US6796970B1
(en)
|
1997-06-17 |
2004-09-28 |
Novo Nordisk A/S |
Dose setting device
|
US5961496A
(en)
|
1997-06-17 |
1999-10-05 |
Novo Nordisk A/S |
Syringe with tiltable nut for quick piston disengagement
|
JP3503129B2
(ja)
|
1997-06-30 |
2004-03-02 |
荒川化学工業株式会社 |
カラーフィルタ層用剥離剤およびカラーフィルタ用ガラス基板の再生方法
|
WO1999002210A1
(en)
|
1997-07-11 |
1999-01-21 |
Novo Nordisk A/S |
An apparatus for the registration of the setting of a medical device
|
WO1999003520A1
(en)
|
1997-07-14 |
1999-01-28 |
Novo Nordisk A/S |
Cylinder ampoule
|
JP2003514587A
(ja)
|
1997-07-14 |
2003-04-22 |
ノボ ノルディスク アクティーゼルスカブ |
射出部品
|
DE19730999C1
(de)
|
1997-07-18 |
1998-12-10 |
Disetronic Licensing Ag |
Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
|
US5921966A
(en)
|
1997-08-11 |
1999-07-13 |
Becton Dickinson And Company |
Medication delivery pen having an improved clutch assembly
|
FR2767479B1
(fr)
|
1997-08-22 |
1999-10-22 |
Aguettant Lab |
Dispositif d'injection de medicament
|
WO1999016485A1
(en)
|
1997-09-29 |
1999-04-08 |
Becton Dickinson And Company |
Injection device and drug cartridge for preventing cross-use of the device and drug cartridge
|
AU4894697A
(en)
|
1997-10-01 |
1999-04-23 |
Flemington Pharmaceutical Corporation |
Buccal, polar and non-polar spray or capsule
|
HUP0004096A3
(en)
|
1997-10-24 |
2001-12-28 |
Novo Nordisk As |
Aggregates of human insulin derivatives and pharmaceutical compositions comprising thereof
|
ATE237636T1
(de)
|
1997-10-24 |
2003-05-15 |
Genentech Inc |
Reinigung von molekülen
|
US6312413B1
(en)
|
1997-10-30 |
2001-11-06 |
Novo Nordisk A/S |
Cylinder ampoule
|
AU1617399A
(en)
|
1997-12-05 |
1999-06-28 |
Eli Lilly And Company |
Glp-1 formulations
|
ZA9811127B
(en)
|
1997-12-09 |
2000-07-11 |
Lilly Co Eli |
Stabilized teriparatide solutions.
|
DE29721752U1
(de)
|
1997-12-09 |
1998-02-12 |
Siemens AG, 80333 München |
Crimpkontakt für Stecksysteme
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
JPH11249087A
(ja)
|
1997-12-18 |
1999-09-17 |
Tome:Kk |
コンタクトレンズ用液剤
|
EP1044015B1
(en)
|
1998-01-09 |
2008-10-08 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides with insulin
|
WO1999034764A2
(en)
|
1998-01-09 |
1999-07-15 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
CN1243578C
(zh)
|
1998-01-30 |
2006-03-01 |
诺沃挪第克公司 |
注射器
|
DE69937272T2
(de)
|
1998-01-30 |
2008-07-10 |
Asubio Pharma Co., Ltd. |
Verfahren zur herstellung eines peptids mittels eines hilfspeptids
|
KR100637433B1
(ko)
|
2004-05-24 |
2006-10-20 |
삼성에스디아이 주식회사 |
발광 표시 장치
|
ES2265181T3
(es)
|
1998-02-13 |
2007-02-01 |
Bioniche Life Sciences Inc. |
Sistema de administracion de farmacos.
|
EP1053001B1
(en)
|
1998-02-13 |
2010-12-15 |
Amylin Pharmaceuticals, Inc. |
Novel mixed amylin activity compounds
|
DE69936446T2
(de)
|
1998-02-13 |
2008-03-06 |
Amylin Pharmaceuticals, Inc., San Diego |
Inotropische und diuretische effekte von exendin und glp-1
|
US6221053B1
(en)
|
1998-02-20 |
2001-04-24 |
Becton, Dickinson And Company |
Multi-featured medication delivery pen
|
US5961495A
(en)
|
1998-02-20 |
1999-10-05 |
Becton, Dickinson And Company |
Medication delivery pen having a priming mechanism
|
US6248095B1
(en)
|
1998-02-23 |
2001-06-19 |
Becton, Dickinson And Company |
Low-cost medication delivery pen
|
AU3247799A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
EP1056774A1
(en)
|
1998-02-27 |
2000-12-06 |
Novo Nordisk A/S |
N-terminally truncated glp-1 derivatives
|
EP1060191B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
WO1999043341A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
|
WO1999043707A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
ATE269103T1
(de)
|
1998-03-13 |
2004-07-15 |
Novo Nordisk As |
Stabilisierte wässerige glukagonlösungen enthaltend detergenzien
|
WO1999047160A1
(en)
|
1998-03-13 |
1999-09-23 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
AU3772199A
(en)
|
1998-05-01 |
1999-11-23 |
University Of Tennessee Research Corporation, The |
Flow cytometric characterization of amyloid fibrils
|
CA2332314A1
(en)
|
1998-06-11 |
1999-12-16 |
Cerus Corporation |
Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
|
EP1094857B1
(en)
|
1998-07-08 |
2003-10-08 |
Novo Nordisk A/S |
A medical delivery device and a cartridge assembly for use in the same
|
AU765584B2
(en)
|
1998-09-17 |
2003-09-25 |
Eli Lilly And Company |
Protein formulations
|
US6033376A
(en)
|
1998-09-30 |
2000-03-07 |
Allergan Sales, Inc. |
Wound shaper sleeve
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
US6605067B1
(en)
|
1998-11-20 |
2003-08-12 |
Novo Nordisk A/S |
Injection needle
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
WO2000037098A1
(en)
|
1998-12-22 |
2000-06-29 |
Eli Lilly And Company |
Shelf-stable formulation of glucagon-like peptide-1
|
EP1609478A1
(en)
|
1999-01-14 |
2005-12-28 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist peptide formulations
|
DE29900482U1
(de)
|
1999-01-14 |
2000-08-31 |
Medico Dev Investment Co |
Injektionsgerät
|
WO2000047332A1
(de)
|
1999-02-14 |
2000-08-17 |
Ing. Erich Pfeiffer Gmbh |
Spender für fliessfähige medien
|
US6258062B1
(en)
|
1999-02-25 |
2001-07-10 |
Joseph M. Thielen |
Enclosed container power supply for a needleless injector
|
US6444788B1
(en)
|
1999-03-15 |
2002-09-03 |
Novo Nordisk A/S |
Ion exchange chromatography of GLP-1, analogs and derivatives thereof
|
BR0009040A
(pt)
|
1999-03-17 |
2001-12-18 |
Novo Nordisk As |
Método para acilar um grupo amino de um peptìdeoou de uma proteìna, e, composto
|
SE9901366D0
(sv)
|
1999-04-16 |
1999-04-16 |
Pharmacia & Upjohn Ab |
Injector device and method for its operation
|
FR2793684B1
(fr)
|
1999-05-17 |
2001-08-10 |
Ethypharm Lab Prod Ethiques |
Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
KR20020059255A
(ko)
|
1999-06-17 |
2002-07-12 |
린다 에스. 스티븐슨 |
저온 저장을 개선하기 위한 PEG-Hb를 사용하는 연속심장 관류 보존
|
DE60036367T2
(de)
|
1999-06-21 |
2008-05-29 |
Eli Lilly And Co., Indianapolis |
Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin-abhängigen diabetes
|
EP1196189A2
(en)
|
1999-06-25 |
2002-04-17 |
Medtronic MiniMed, Inc. |
Multiple agent diabetes therapy
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
US6936032B1
(en)
|
1999-08-05 |
2005-08-30 |
Becton, Dickinson And Company |
Medication delivery pen
|
TW453884B
(en)
|
1999-09-16 |
2001-09-11 |
Novo Nordisk As |
Dose setting limiter
|
DE60024118T2
(de)
|
1999-09-20 |
2006-07-27 |
Eli Lilly And Co., Indianapolis |
Verwendung einer parathyroidhormone zur reduktion des krebsrisikos
|
US6514230B1
(en)
|
1999-10-12 |
2003-02-04 |
Novo Nordisk A/S |
Air shot mechanism for electronic injection devices
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
PT1242121E
(pt)
|
1999-12-16 |
2005-05-31 |
Lilly Co Eli |
Composicoes polipeptidicas com estabilidade melhorada
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
AU2353701A
(en)
|
2000-01-11 |
2001-07-24 |
Novo Nordisk A/S |
Transepithelial delivery of glp-1 derivatives
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
HUP0204281A3
(en)
|
2000-01-27 |
2007-03-28 |
Lilly Co Eli |
Process for sulubilizing glucagon-like peptide 1 (glp-1) compounds
|
EP1396499A3
(en)
|
2000-01-27 |
2004-12-29 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
GB0007071D0
(en)
|
2000-03-24 |
2000-05-17 |
Sams Bernard |
One-way clutch mechanisms and injector devices
|
AU2001248277A1
(en)
|
2000-04-06 |
2001-10-23 |
Novo-Nordisk A/S |
Shock heat treatment of polypeptides
|
US6692472B2
(en)
|
2000-05-04 |
2004-02-17 |
Novo Nordisk A/S |
Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
|
CA2380423A1
(en)
|
2000-05-17 |
2001-11-22 |
Bionebraska, Inc. |
Peptide pharmaceutical formulations
|
US6716198B2
(en)
|
2000-05-18 |
2004-04-06 |
Novo Nordisk A/S |
Injection device
|
US6547763B2
(en)
|
2000-05-18 |
2003-04-15 |
Novo Nordisk A/S |
Dose display for injection device
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
ATE424413T1
(de)
|
2000-06-16 |
2009-03-15 |
Lilly Co Eli |
Analoge des glucagon-ähnlichen peptids-1
|
US6663602B2
(en)
|
2000-06-16 |
2003-12-16 |
Novo Nordisk A/S |
Injection device
|
US6613019B2
(en)
|
2000-07-14 |
2003-09-02 |
Novo Nordisk A/S |
Liquid medication delivery device and a method of delivering an intended dose
|
WO2002024257A1
(en)
|
2000-09-22 |
2002-03-28 |
Novo Nordisk A/S |
A medication delivery device
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
ES2311560T3
(es)
|
2000-12-07 |
2009-02-16 |
Eli Lilly And Company |
Proteinas de fusion glp-1.
|
CN1501809B
(zh)
|
2000-12-13 |
2012-10-10 |
伊莱利利公司 |
应用胰高血糖素样促胰岛肽的长期治疗方案
|
WO2002048192A2
(en)
|
2000-12-13 |
2002-06-20 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
US20020151467A1
(en)
|
2000-12-21 |
2002-10-17 |
Leung Frank K. |
Methods and compositions for oral insulin delivery
|
US6899699B2
(en)
|
2001-01-05 |
2005-05-31 |
Novo Nordisk A/S |
Automatic injection device with reset feature
|
GB2371227A
(en)
|
2001-01-10 |
2002-07-24 |
Grandis Biotech Gmbh |
Crystallisation - resistant aqueous growth hormone formulations
|
DE60224167T2
(de)
|
2001-02-14 |
2008-12-04 |
Novo Nordisk A/S |
Elektronisch gesteuerte injektions- oder infusionsvorrichtung
|
AU2002233089B2
(en)
|
2001-02-16 |
2005-12-22 |
Conjuchem Biotechnologies Inc. |
Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
|
EP1949908A1
(en)
|
2001-03-07 |
2008-07-30 |
Novo Nordisk A/S |
Combined use of derivatives of GLP-1 analogs and PPAR ligands
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
CA2445511C
(en)
|
2001-05-16 |
2010-03-16 |
Eli Lilly And Company |
Medication injector apparatus with drive assembly that facilitates reset
|
EP1391209A4
(en)
|
2001-05-30 |
2009-12-16 |
Chugai Pharmaceutical Co Ltd |
PROTEIN PREPARATION
|
GB0113881D0
(en)
|
2001-06-07 |
2001-08-01 |
Innovate Biomed Ltd |
Foil cutting system
|
ES2298378T3
(es)
|
2001-06-28 |
2008-05-16 |
Novo Nordisk A/S |
Formulacion estable de glp-1 modificado.
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
DE10163326A1
(de)
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Verabreichungsgerät mit Dosiervorrichtung
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
CA2452044A1
(en)
|
2001-08-28 |
2003-03-13 |
Eli Lilly And Company |
Pre-mixes of glp-1 and basal insulin
|
US6676641B2
(en)
|
2001-09-05 |
2004-01-13 |
Futura Medical Technologies, Inc. |
Retractable hypodermic syringe
|
PL377687A1
(pl)
|
2001-10-18 |
2006-02-06 |
Bristol-Myers Squibb Company |
Środki naśladujące ludzki peptyd glukagonopodobny typu 1 i ich zastosowanie w leczeniu cukrzycy i stanów związanych z cukrzycą
|
JP2005508360A
(ja)
|
2001-10-19 |
2005-03-31 |
イーライ・リリー・アンド・カンパニー |
Glp−1およびインスリンの二相混合物
|
MXPA04008068A
(es)
|
2002-02-20 |
2004-11-26 |
Lilly Co Eli |
Metodo para administrar moleculas de glp-1.
|
EP1490031A1
(en)
|
2002-03-07 |
2004-12-29 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
DK1344533T3
(da)
|
2002-03-15 |
2007-01-08 |
Natimmune As |
Farmaceutiske præparater, der omfatter mannosebindende lectin
|
JP2005535569A
(ja)
|
2002-04-04 |
2005-11-24 |
ノボ・ノルデイスク・エー/エス |
Glp−1アゴニスト及び心臓血管合併症
|
AU2003250915A1
(en)
|
2002-07-09 |
2004-01-23 |
Sandoz Ag |
LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL
|
JP2005532129A
(ja)
|
2002-07-10 |
2005-10-27 |
ノボ・ノルデイスク・エー/エス |
投与量設定リミッタを備える注入器
|
US6945961B2
(en)
|
2002-07-10 |
2005-09-20 |
Novo Nordisk A/S |
Injection device
|
EP1391794A1
(en)
|
2002-07-23 |
2004-02-25 |
Novo Nordisk A/S |
Device with time indicating means
|
WO2004020026A1
(en)
|
2002-08-29 |
2004-03-11 |
Novo Nordisk A/S |
Frontloaded injection device
|
WO2004028598A1
(en)
|
2002-09-24 |
2004-04-08 |
Shl Medical Ab |
Injecting device
|
DE60321473D1
(de)
|
2002-09-25 |
2008-07-17 |
Novo Nordisk As |
Aufreinigungsverfahren, das eine mikrofiltration bei erhöhten temperaturen beinhaltet
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
US8168233B2
(en)
|
2002-10-18 |
2012-05-01 |
Amylin Pharmaceuticals, Inc. |
Treatment of pancreatitis with amylin
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
AU2003297356A1
(en)
|
2002-12-17 |
2004-07-14 |
Amylin Pharmaceuticals, Inc. |
Prevention and treatment of cardiac arrhythmias
|
US20050019400A1
(en)
|
2003-01-27 |
2005-01-27 |
Deveney Thomas William |
Controlled-release drug delivery system
|
GB0304824D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0304822D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0304823D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0306642D0
(en)
|
2003-03-22 |
2003-04-30 |
Dca Design Int Ltd |
Improvements in and relating to an injector for a medical product
|
GB0308267D0
(en)
|
2003-04-10 |
2003-05-14 |
Dca Design Int Ltd |
Improvements in and relating to a pen-type injector
|
WO2004089985A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Stable pharmaceutical compositions
|
US8008255B2
(en)
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
ES2380437T3
(es)
|
2003-06-03 |
2012-05-11 |
Novo Nordisk A/S |
Composiciones farmacéuticas de péptido GLP-1 estabilizadas
|
CA2527743A1
(en)
|
2003-06-03 |
2004-12-09 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
SI1656170T1
(sl)
|
2003-08-12 |
2019-05-31 |
Eli Lilly And Company |
Oprema za izdajanje zdravil s trojnim vijačnim navojem za mehanski pospešek
|
EP1663289A2
(en)
|
2003-08-29 |
2006-06-07 |
Amylin Pharmaceuticals, Inc. |
Methods for treating or ameliorating ghrelin-associated diseases and disorders
|
TW200526254A
(en)
|
2003-09-19 |
2005-08-16 |
Novo Nordisk As |
Novel GLP-1 derivatives
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
DK1682178T3
(da)
|
2003-11-04 |
2010-10-04 |
Novartis Vaccines & Diagnostic |
Fremgangsmåder til terapi af cancere der udtrykker CD-40-antigenet
|
BR122018071808B8
(pt)
|
2003-11-06 |
2020-06-30 |
Seattle Genetics Inc |
conjugado
|
JP4800959B2
(ja)
|
2003-11-13 |
2011-10-26 |
ノヴォ ノルディスク アー/エス |
糖尿病及び過食症を治療するためのglp−1ペプチド及び短時間作用型インスリンペプチドを含む、非経口投与用の可溶性医薬組成物
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
RU2421238C2
(ru)
|
2003-11-20 |
2011-06-20 |
Ново Нордиск А/С |
Пептидная композиция, содержащая пропиленгликоль, являющаяся оптимальной для изготовления и применения в инъекционных устройствах
|
EP1694278A4
(en)
|
2003-12-16 |
2009-08-12 |
Ipsen Pharma |
GLP-1 PHARMACEUTICAL COMPOSITIONS
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
BRPI0507623A
(pt)
|
2004-02-11 |
2007-07-03 |
Amylin Pharmaceuticals Inc |
peptìdeos da famìlia da amilina e métodos para prepará-los e empregá-los
|
EP1765406A4
(en)
|
2004-05-21 |
2012-11-28 |
Mediplex Corp |
ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
|
US7448385B2
(en)
|
2004-06-07 |
2008-11-11 |
Purepharm Inc. |
Nasal adaptation of an oral inhaler device
|
EP1758575A1
(en)
|
2004-06-11 |
2007-03-07 |
Novo Nordisk A/S |
Counteracting drug-induced obesity using glp-1 agonists
|
EP1906991A2
(en)
|
2004-06-28 |
2008-04-09 |
Novo Nordisk A/S |
Use of glp-1 receptor agonists and/or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i, diabetes type ii and impaired pancreatic beta-cell function
|
EP1789075A4
(en)
|
2004-08-25 |
2009-07-01 |
Uab Research Foundation |
ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
|
EP2286840A3
(en)
|
2004-11-01 |
2013-09-04 |
Amylin Pharmaceuticals, LLC |
Treatment of obesity and related diseases
|
WO2007055728A1
(en)
*
|
2005-11-01 |
2007-05-18 |
Amylin Pharmaceuticals, Inc. |
Treatment of obesity and related disorders
|
EP1814581B1
(en)
|
2004-11-12 |
2016-03-16 |
Novo Nordisk A/S |
Stable formulations of peptides comprising an acylated glp-1 analogue and a basal insuline
|
CN112618700A
(zh)
|
2004-11-12 |
2021-04-09 |
诺和诺德公司 |
促胰岛素肽的稳定制剂
|
US7910577B2
(en)
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
DK1843809T3
(en)
|
2005-01-21 |
2017-07-31 |
Novo Nordisk As |
AUTOMATIC INJECTION DEVICE WITH A TOP TRANSMISSION MECHANISM
|
EP2353590A1
(en)
*
|
2005-02-15 |
2011-08-10 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
US20090238820A1
(en)
|
2005-03-08 |
2009-09-24 |
Allan Corey M |
ANTI-MAdCAM ANTIBODY COMPOSITIONS
|
US8834891B2
(en)
|
2005-03-14 |
2014-09-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Immunogenic compositions comprising Lawsonia intracellularis
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
EP1912666A2
(en)
|
2005-07-22 |
2008-04-23 |
Amylin Pharmaceuticals, Inc. |
Use of amylin and amylin agonists as cardioprotective or myoprotective agents
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
AU2006331790A1
(en)
|
2005-12-19 |
2007-07-05 |
Comentis, Inc. |
Topical mecamylamine formulations for ocular administration and uses therof
|
CN104383526B
(zh)
|
2005-12-29 |
2018-09-18 |
贝林格尔.英格海姆维特梅迪卡有限公司 |
Pcv2免疫原性组合物用于减轻猪临床症状的用途
|
JP2009533460A
(ja)
|
2006-04-13 |
2009-09-17 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
hGLP−1、エクセンジン−4およびその類似体の医薬組成物
|
EP2049567A2
(en)
|
2006-07-18 |
2009-04-22 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
TW200843794A
(en)
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
GB0704846D0
(en)
|
2007-03-13 |
2007-04-18 |
Futura Medical Dev Ltd |
Topical pharmaceutical formulation
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
US20080293814A1
(en)
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
EP2190460B1
(en)
|
2007-09-05 |
2014-12-17 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
JP2010539037A
(ja)
|
2007-09-11 |
2010-12-16 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
治療剤としてのペプチドの使用
|
WO2009051992A1
(en)
|
2007-10-19 |
2009-04-23 |
Bausch & Lomb Incorporated |
Compositions and methods for treating diseases involving ocular angiogenesis by inhibiting one or more selected receptor tyrosine kinases
|
AU2007360979B2
(en)
|
2007-11-14 |
2014-04-10 |
Amylin Pharmaceuticals, Llc |
Methods for treating obesity and obesity related diseases and disorders
|
US20090186819A1
(en)
|
2007-12-11 |
2009-07-23 |
Marieve Carrier |
Formulation of insulinotropic peptide conjugates
|
EP2340261B1
(en)
|
2008-10-21 |
2017-12-20 |
Novo Nordisk A/S |
Amylin derivatives
|
WO2010107874A2
(en)
|
2009-03-17 |
2010-09-23 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition using amylin agonists
|
EP2437816B1
(en)
*
|
2009-06-04 |
2013-04-24 |
Novo Nordisk Health Care AG |
Mixing device with piston coupling arrangement
|
CA2769340C
(en)
|
2009-07-31 |
2018-09-11 |
Harald Rau |
Prodrugs comprising an insulin linker conjugate
|
SG178195A1
(en)
|
2009-07-31 |
2012-03-29 |
Sanofi Aventis Deutschland |
Long acting insulin composition
|
WO2011050008A2
(en)
|
2009-10-19 |
2011-04-28 |
Amylin Pharmaceuticals, Inc. |
Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders
|
MX2012006450A
(es)
|
2009-12-10 |
2012-06-28 |
Merck Patent Gmbh |
Composicion farmaceutica que comprende oligopeptidos.
|
WO2011073328A1
(en)
|
2009-12-16 |
2011-06-23 |
Novo Nordisk A/S |
Glp-1 receptor agonist compounds with a modified n-terminus
|
WO2011104378A1
(en)
|
2010-02-26 |
2011-09-01 |
Novo Nordisk A/S |
Peptides for treatment of obesity
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
WO2011109784A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Formulation of insulinotropic peptide conjugates
|
CA2792663A1
(en)
|
2010-03-26 |
2011-09-29 |
Novo Nordisk A/S |
Novel glucagon analogues
|
WO2012015975A2
(en)
|
2010-07-28 |
2012-02-02 |
Amylin Pharmaceuticals, Inc. |
Glp-1 receptor agonist compounds having stabilized regions
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
ES2683372T3
(es)
|
2010-11-09 |
2018-09-26 |
Novo Nordisk A/S |
Derivados de GLP-1 acilados con un conector nuevo
|
JP2014500086A
(ja)
|
2010-12-06 |
2014-01-09 |
ノボ ノルディスク ヘルス ケア アーゲー |
ホイール操作薬物送達デバイス
|
JP2014507429A
(ja)
|
2011-02-04 |
2014-03-27 |
バイオコピア リミテッド |
心血管疾患の治療のための組成物および方法
|
US20130035281A1
(en)
|
2011-02-09 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN103619175B
(zh)
|
2011-04-12 |
2016-08-17 |
诺沃—诺迪斯克有限公司 |
双酰化glp-1衍生物
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
US8722849B2
(en)
|
2011-06-10 |
2014-05-13 |
Novo Nordisk A/S |
Polypeptides
|
DK2729160T3
(da)
|
2011-07-08 |
2019-07-01 |
Aegerion Pharmaceuticals Inc |
Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet
|
BR112014001335A2
(pt)
*
|
2011-07-20 |
2017-02-21 |
Hospira Inc |
método para tratar dor pós-operatória em um mamífero e método para tratar dor em um mamífero
|
US9132170B2
(en)
|
2011-07-29 |
2015-09-15 |
Case Western Reserve University |
Compositions and methods for treating cognitive deficits
|
ES2626013T3
(es)
|
2011-09-06 |
2017-07-21 |
Novo Nordisk A/S |
Derivados de GLP-1
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
EP2788027A2
(en)
|
2011-12-09 |
2014-10-15 |
Novo Nordisk A/S |
Glp-1 agonists
|
CN104185639B
(zh)
|
2012-03-01 |
2018-06-19 |
诺和诺德股份有限公司 |
Glp-1前体药物
|
CN102579350B
(zh)
|
2012-03-02 |
2013-04-24 |
海南灵康制药有限公司 |
右旋布洛芬脂质体固体制剂
|
EP2833892A4
(en)
|
2012-04-02 |
2016-07-20 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY
|
WO2013151729A1
(en)
|
2012-04-03 |
2013-10-10 |
Trustees Of Boston University |
Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
|
PL2838914T3
(pl)
|
2012-04-19 |
2017-11-30 |
Novo Nordisk A/S |
Analogi ludzkiej amyliny
|
US10000542B2
(en)
|
2012-05-08 |
2018-06-19 |
Novo Nordisk A/S |
Double-acylated GLP-1 derivatives
|
EP2846824B1
(en)
|
2012-05-08 |
2017-04-05 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
US20150174209A1
(en)
|
2012-05-25 |
2015-06-25 |
Amylin Pharmaceuticals. Llc |
Insulin-pramlintide compositions and methods for making and using them
|
JP6085026B2
(ja)
|
2012-06-19 |
2017-02-22 |
デビオファーム インターナショナル エスエーDebiopharm International Sa |
(e)−n−メチル−n−((3−メチルベンゾフラン−2−イル)メチル)−3−(7−オキソ−5,6,7,8−テトラヒドロ−1,8−ナフチリジン−3−イル)アクリルアミドのプロドラッグ誘導体
|
CA2877056A1
(en)
|
2012-07-01 |
2014-01-09 |
Novo Nordisk A/S |
Use of long-acting glp-1 peptides
|
EP2908844A1
(en)
|
2012-10-17 |
2015-08-26 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
US20140187635A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Themis Medicare Limited |
Diclofenac compositions
|
PT2970389T
(pt)
|
2013-03-15 |
2020-10-21 |
Rhythm Pharmaceuticals Inc |
Composições farmacêuticas
|
PL2991671T3
(pl)
|
2013-05-02 |
2019-01-31 |
Novo Nordisk As |
Doustne dawkowanie związków glp-1
|
CA2911818A1
(en)
|
2013-05-10 |
2014-11-13 |
Nimbus Apollo, Inc. |
Acc inhibitors and uses thereof
|
US20160136246A1
(en)
*
|
2013-06-21 |
2016-05-19 |
Novo Nordisk A/S |
Novel Uses of GLP-1 Receptor Agonists in Patients Treated with Insulin and/or Suffering from Type 1 Diabetes
|
MX2015016875A
(es)
*
|
2013-07-04 |
2016-04-07 |
Novo Nordisk As |
Derivados de peptidos similares a peptido similar a glucagon 1 (glp-1) y sus usos.
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
CN103405753B
(zh)
|
2013-08-13 |
2016-05-11 |
上海仁会生物制药股份有限公司 |
稳定的促胰岛素分泌肽水针药物组合物
|
EP3129041B1
(en)
|
2014-04-07 |
2019-06-12 |
Novo Nordisk A/S |
Double-acylated glp-1 compounds
|
EP3160491A4
(en)
|
2014-06-25 |
2018-01-17 |
GlaxoSmithKline LLC |
Pharmaceutical compositions
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
WO2016038521A1
(en)
|
2014-09-08 |
2016-03-17 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of liraglutide
|
CN105777872B
(zh)
|
2014-12-16 |
2019-06-07 |
深圳翰宇药业股份有限公司 |
一种萨摩鲁肽的纯化方法
|
US20190060410A1
(en)
|
2015-05-13 |
2019-02-28 |
Xiaoni LIU |
Pharmaceutical Formulation Comprising GLP-1 Analogue and Preparation Method Thereof
|
TW201706291A
(zh)
|
2015-07-10 |
2017-02-16 |
賽諾菲公司 |
作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
|
US20170071970A1
(en)
*
|
2015-09-15 |
2017-03-16 |
Janssen Pharmaceutica Nv |
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
|
WO2017114921A1
(en)
|
2015-12-30 |
2017-07-06 |
Novo Nordisk A/S |
Mechanism for sequential dose delivery
|
US10946074B2
(en)
|
2016-03-03 |
2021-03-16 |
Novo Nordisk A/S |
GLP-1 derivatives and uses thereof
|
JP7221694B2
(ja)
|
2016-04-28 |
2023-02-14 |
ノヴォ ノルディスク アー/エス |
心血管状態におけるセマグルチド
|
JP2019535835A
(ja)
|
2016-11-22 |
2019-12-12 |
バイオコン リサーチ リミテッドBiocon Research Limited |
Glp−1類似体の医薬組成物
|
GB201621987D0
(en)
|
2016-12-22 |
2017-02-08 |
Archer Virgil L See Archer Sheri A Arecor Ltd |
Novel composition
|
WO2018139991A1
(en)
|
2017-01-24 |
2018-08-02 |
Macregen, Inc. |
Treatment of age-related degeneration and other eye diseases with apolipoprotein mimetics
|
WO2018153849A1
(en)
*
|
2017-02-21 |
2018-08-30 |
Sanofi |
Azetidine compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
|
PE20211202A1
(es)
*
|
2017-08-24 |
2021-07-05 |
Novo Nordisk As |
Composiciones de glp-1 y sus usos
|
CA3078652A1
(en)
*
|
2017-10-12 |
2019-04-18 |
Novo Nordisk A/S |
Semaglutide in medical therapy
|
WO2019122109A1
(en)
*
|
2017-12-21 |
2019-06-27 |
Sanofi |
Liquid pharmaceutical composition
|
TWI705820B
(zh)
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
EP3811962A4
(en)
|
2018-06-25 |
2022-03-16 |
JCR Pharmaceuticals Co., Ltd. |
PROTEIN AQUEOUS LIQUID FORMULATION
|
PL3870213T3
(pl)
|
2018-10-26 |
2023-11-20 |
Novo Nordisk A/S |
Stabilne kompozycje semaglutydu i ich zastosowania
|